Join Dr. Steve Gard, editor-in-chief of the Journal of Prosthetics and Orthotics, as he talks with Philip Muccio, founder & CEO of AxioBionics, about his study on Neuromuscular Electrical Stimulation (NMES) and its impact on arm use in hemiparetic and hemiplegic patients. They explore the development of the Axiobionics Biosleeve, study findings showing increased arm movement over time, and how these results challenge traditional recovery expectations. The conversation also looks at future research and the potential of advanced technologies to improve patient outcomes.
Show notes
O&P Research Insights is produced by Association Briefings.